16
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Chronic Arthritis and gamma-Heavy Chain Disease: Coincidence or Pathogenic Link?

Pages 258-264 | Published online: 12 Jul 2009

References

  • Fermand JP, Brouet JC, Danon F, Seligmann M. Gamma heavy chain «Disease»: Heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature. Medi-cine 1989;68:321 —35.
  • Franklin EC, Mowenstein J, Bigelow B, Meltzer M. Heavy chain disease. A new disorder of serum gammaglobulins. Report of the first case. Am J Med 1964;37:332 —50.
  • Galanti LM, Doyen C, Vander Maelen C, Daparé N, Bosly A, Pouthier F, et al. Biological diagnosis of a gamma-l-heavy chain disease in an asymptomatic patient. Eur J Haematol 1995;54:202–4.
  • Alexander A, Anicito I, Buxbaum J. Gamma heavy chain dis-ease in man. Genomic sequence reveals two noncontiguous deletions in a single gene. J Clin Invest 1988;82:1244–52.
  • Khamlichi AA, Aucouturier P, Preud'Homme JL, Cogne M. Structure of abnormal heavy chains in human heavy-chain-deposition disease. Eur J Biochem 1995;229:54–60.
  • Brandtzaeg P. Prolonged incubation time in immunohisto-chemistry: effects on fluorescence staining of immunoglobulins and epithelial components in ethanol- and formaldehyde-fixed paraffin-embedded tissues. J Histochem Cytochem 1981;29:1302–15.
  • Brandtzaeg P, Kett K, Rognum TO, Söderström T, Petruson B, Hanson LA. Distribution of mucosal IgA and IgG subclass-producing immunocytes and alterations in various disorders. Monogr Allergy 1986;20:179–94.
  • Mason DY, Taylor CR. The distribution of muramidase (lyso-zyme) in human tissues. J Clin Pathol 1975;28:124–32.
  • Larsen A, Dale K, Eek M. Radiographic evaluation of rheuma-toid arthritis and related conditions by standard reference films. Acta Radiol Diag 1977;18:481–91.
  • Comenzo RL, Vosburgh E, Simms RW, Bergethon P, Sarnacki D, Finn K, et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: One-year follow-up in five patients. Blood 1996;88:2801–6.
  • Stenstad T, Magnus JH, Husby G. Characterization of proteo-glycans associated with mouse splenic AA amyloidosis. Bio-chem J 1994;303:663–70.
  • Omtvedt LA, Husby G, Cornwell GG III, Kyle RA, Sletten K. The amino acid sequence of the glycosylated amyloid immuno-globulin light chain proteins AL MS. Scand J Immunol 1997;45:551–6.
  • Huck S, Fort P, Crawford DH, Lefranc MP, Lefranc G. Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human Cy genes. Nucleic Acids Res 1986;14: 1779–89.
  • Husby G. Amyloidosis. Serium Arthritis Rheum 1992;22: 67–82.
  • Vitali C, Baglioni P, Vivaldi I, Cacialli R, Tavoni A, Bombardieri S. Erosive arthritis in monoclonal gammopathy of uncertain significance: Report of four cases. Arthritis Rheum 1991;34:1600–15.
  • Eulitz M, Weiss DT, Solomon A. Immunoglobulin heavy-chain-associated amyloidosis. Proc Natl Acad Sci USA 1990;87:6542–6.
  • Munthe E, Natvig JB. Complement-fixing intracellular com-plexes of IgG rheumatoid factor in rheumatoid plasma cells. Scand J Immunol 1972;1:217–29.
  • Mellbye OJ, Vartdal F, Pahle J, Mollnes TE. IgG and IgA sub-class distribution of total immunoglobulin and rheumatoid fac-tors in rheumatoid tissue plasma cells. Scand J Rheumatol 1990;19:333–40.
  • Arend WP. The pathophysiology and treatment of rheumatoid arthritis. Arthritis Rheum 1997;40:595–7.
  • Lust JA. Role of cytokines in the pathogenesis of monoclonal gammopathies. Mayo Clin Proc 1994;69:691–7.
  • Waage A, Espevik T, Kaufmann C, Husby G. Interleukin 6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol 1989;50:394–8.
  • Bataille R, Harousseau JL. Multiple myeloma. N Engl J Med 1997;336:1657–64.
  • Firestein GS, Zvaifler NJ. Anticytokine therapy in rheumatoid arthritis. N Engl J Med 1997;337:195–7.
  • Arend WP, Dayer J-P. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305–15.
  • Mfiller-Ladner U, Kriegsmann J, Gay RE, Gay S. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:675–90.
  • Moskovitz T, Jacobson DR, Buxbaum JN. N-ras oncogene activation in a patient with 7 heavy chain disease. Am J Hema-tol 1992;41: 302–3.
  • Van de Rijn M, Cleary ML, Variakojis D, Warnke RA, Chang PP, Kamel OW. Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:638–42.
  • Albani S, Carson DA, Roudier J. Genetic and environmental factors in the immunopathogenesis of rheumatoid arthritis. Rheum Dis Clin North Am 1992;18:729–40.
  • Guglielmi P, Bakhshi A, Cogne M, Seligmann M, Korsmeyer SJ. Multiple genomic defects result in an alternative RNA splice creating a human 7 H Chain disease protein. J Immunol 1988;141: 1762–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.